首页|Effectiveness of a Brief Mindfulness-Based Intervention of “STOP touching your face” During the COVID-19 Pandemic: a Randomized Controlled Trial
Effectiveness of a Brief Mindfulness-Based Intervention of “STOP touching your face” During the COVID-19 Pandemic: a Randomized Controlled Trial
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NSTL
Springer Nature
Abstract Objectives Avoiding touching the eyes, nose, and mouth (T-zone) is a strategy to reduce the spread of COVID-19. This study evaluated the effectiveness of a brief mindfulness-based intervention (MBI) named “STOP (Stop, Take a Breath, Observe, Proceed) touching your face” for reducing face-touching behavior.Methods In this online-based, two-arm, wait-list, randomized controlled trial, eligible participants were randomly assigned to the intervention (n?=?545) or control group (n?=?545). The results of 60-min self-monitoring of face-touching behavior were reported before and after the intervention. Reduction of the percentage of T-zone touching was the primary outcome, and reduction of face-touching frequency was a key secondary outcome. Outcomes were analyzed on an intention-to-treat (ITT) basis with a complete case analysis (CCA).Results ITT analysis revealed that the percentage of T-zone touching was significantly reduced by 8.1% in the intervention group (from 81.1 to 73.0%, RR?=?0.901, OR?=?0.631, RD?=????0.081, p?=?0.002), and insignificantly reduced by 0.6% in the control group (from 80.0 to 79.4%, p?=?0.821). Fewer participants performed T-zone touching in the intervention group than in the control group (73.0% vs. 79.4%, RR?=?0.919, OR?=?0.700, RD?=????0.064, p?=?0.015) after the intervention, and there was a greater reduction of T-zone touching frequency in the intervention group than in the control group [mean?±?SD: 1.7?±?5.13 vs. 0.7?±?3.98, mean difference (95% CI): 1.03 (0.48 to 1.58), p?<?0.001, Cohen’s d?=????0.218]. The above results were further confirmed by CCA.Conclusions This brief mindfulness-based intervention was potentially effective at reducing the spread of COVID-19 and could be further investigated as an intervention for preventing other infectious diseases spread by hand-to-face touching.Trial Registration ClinicalTrials.gov NCT04330352.